Epithelial-to-mesenchymal transition (EMT) programs provide cancer cells with invasive and survival capacities that might favor metastatic dissemination. Whilst signaling cascades triggering EMT have been extensively studied, the impact of EMT on the crosstalk between tumor cells and the tumor microenvironment remains elusive. We aimed to identify EMT- 
Introduction
Known as developmental programs transforming epithelial cells into mesenchymal cells [1, 2] , epithelial-to-mesenchymal transitions (EMT) trigger a morphological switch from a cobblestone shape to an elongated form, alongside decreased expression of epithelial markers (i.e. E-cadherin) and gains of mesenchymal markers (i.e. vimentin) [3, 4] . A variety of EMTinducing extracellular signals and signaling pathways converge to induce expression of EMTtranscription factors (EMT-TF) [5, 6] including those of the Snail family (Snail and Slug), ZEB1 and ZEB2, Twist, E47, Brachyury and others. Although a major and well-described effect of EMT-TFs is E-cadherin repression [6] [7] [8] , EMT-TFs can activate or repress a variety of target genes [9] [10] [11] ( [12] for a review). In the most studied Snail family, the two human homologs Snail and Slug contain a Zinc finger cluster enabling interaction with specific DNA sequences called E-boxes, first discovered on the chd1/E-cadherin promoter [7, 13] . Snail expression is connected to disease progression, for instance with lymph node metastasis in breast cancer [14] and with poor overall survival in ovarian cancer [15] . In mouse models, Snail has been shown to trigger inflammation and hyperplasia followed by tumor formation [16] , to accelerate metastasis through enhanced invasion and immunosuppression [17] and to increase blood vessel density [18] . Snail has also been associated to cancer stemness in colorectal cancer cells [19] .
Partial, reversible EMT has been suggested to occur at different steps of cancer progression [3, [20] [21] [22] and recent findings indicate that EMT is particularly involved in tumor cell escape from the primary tumor and the release of circulating tumor cells (CTCs) [23, 24] .
CTCs from breast cancer patients have accordingly been shown to express EMT markers [20, 25, 26] and EMT-derived phenotypes are observed in about 15% of invasive ductal carcinomas and relate to higher histological grade, higher rate of loco-regional recurrence [8] , chemoresistance [27] and presence of lymph node metastases [14] . EMT markers are particularly associated with triple-negative breast cancers (TNBCs) [14, [28] [29] [30] , an aggressive subgroup for which there is no efficient therapy as yet [31] .
Although the cellular pathways leading to EMT and their contribution to intrinsically enhanced invasive properties of tumor cells have been extensively studied, the impact of EMT programs on the crosstalk between tumor cells and the tumor microenvironment remains elusive. Yet, metastatic dissemination largely relies on tumor-stroma interactions and cytokines represent major soluble mediators implicated in tumor-stroma crosstalk [32] [33] [34] .
Cytokine overexpression by cancer cells has been reported in many cancers including breast and lung [35] [36] [37] , although the mechanisms involved are still largely uncovered. We hypothesized that EMT programs modulate the microenvironment, thereby stimulating recruitment of a variety of host cells and elaborating a permissive milieu for tumor progression.
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Materials and methods

Immunohistochemical study on human samples
Human breast tissues were obtained from 40 Table S1 . Semi-quantitative scoring methods are described in Supplemental materials and methods.
Cell culture and growth factor induction of EMT
Cancer cell lines were from ATCC (American Type Culture Collection, Manassas, VA). The A549 and MDA-MB-468 cells used are luciferase-expressing clones purchased (Caliper Life Sciences, Hopkinton, MA) and generated as previously described [21] . A description of culture reagents is provided in Supplemental materials and methods. MDA-MB-468 and A549 were seeded (2x10 5 and 1.5x10 5 cells respectively) in 6-well plates and immediately treated with 20 ng/ml recombinant EGF (Sigma, St-Louis, MO) or 5 ng/ml recombinant TGF-β (R&D Systems, Minneapolis, MN) respectively. Twenty four hours after seeding, the medium was replaced by serum-free medium (complemented or not with EGF or TGF-β) and left 24 supplemental hours. Conditioned media were then collected and RNA extracted. A detailed procedure for subsequent cytokine array is provided in Supplemental materials and methods.
Plasmid and siRNA transfections
Cells were seeded as described above and transfected 48 hours later in serum-free medium with Lipofectamine RNAiMax (Life Technologies, Carlsbad, CA). SiRNA sequences are provided in Supplemental materials and methods. Plasmids were transfected using the ExtremeGENE 9 reagent (Roche, Basel, Switzerland) in serum-free medium and RNA was extracted 48 hours later. The plasmids used were pCMV-Tag2B Snail-6SA (Addgene, Cambridge, MA, USA) and pCMV-Tag2B as an empty control vector.
Recombinant proteins, ELISA, Reverse Transcription and PCR
Recombinant IL-8 was from R&D and recombinant ICAM-1 from Peprotech (Hamburg, Germany). The IL-6 ELISA kit was a Cytoset kit (Invitrogen, Carlsbad, California). Other
ELISAs were performed with Duoset kits (R&D). After RNA extraction (High Pure RNA Isolation Kit, Roche) and reverse transcription (First Strand cDNA Synthesis kit, Roche), real time PCR was performed with the LightCycler480 Probes Master kit and the Universal Probe Library system (Roche). Alternatively, endpoint PCR was performed for a defined number of PCR cycles after which amplicons were separated on acrylamide gels stained with GelStar (Lonza, Basel, Switzerland). Primer sequences are provided in Supplemental Table S2 . Gene expression was normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or to TBP (TATA-box binding protein).
Sponge assay, immunofluorescence and FACS
Sponge assays were performed as previously described [38] . Briefly, gelfoam sponges (Pfizer, New-York, NY) were soaked in conditioned medium concentrated with Amicon filters (Millipore, Darmstadt, Germany). We used conditioned medium from non-treated ("C") or EGF-treated MDA-MB-468 ("EGF") or from non-treated ("C") or TGF-β-treated A549 ("TGF-β"). To exclude EGF or TGF-β direct effects on host cell recruitment, remaining levels of EGF and TGF-β in the treated conditions were measured by ELISA and the equivalent amounts were added into corresponding conditioned medium of untreated cells, yielding "C+E" and "C+T" conditions used as controls in all experiments. Experimente including the control medium without addition of EGF ("C") were also performed. Sponges were subcutaneously inserted into the ears of C57BL/6 mice (Charles River, Chatillon-surChalarone, France) and left for 3 days or 3 weeks. In some experiments, concentrated conditioned medium from EGF-treated MDA-MB-468 was pre-incubated overnight with blocking antibody (Supplemental Table S1 ) or the corresponding negative control antibody (Dako, Glostrup, Denmark), before depletion by immunoprecipitation using protein-Gcoupled Dynabeads (Lifetechnologies). A description of ear processing, staining and computer-assisted quantification of angiogenesis and myeloid cell distribution is provided in Supplemental materials and methods. For FACS, sponges were collected and dissociated using PBS-EDTA for 10 minutes at 37°C. Sponge isolates and flushed bone marrows were centrifuged and suspended in PBS containing 3% serum, filtered and processed for staining.
Antibodies are listed in Supplemental Table S1 .
Aortic ring assays and transwell migration assays
The protocol for aortic ring assays has been described [39] 
Laser-Capture Microdissection on MDA-MB-468 xenografts
MDA-MB-468 cell tumors were grown for 100 days following subcutaneous injection in SCID mice as previously described [21] . Tumors were embedded in OCT (VWR, Radnor, PA). Microdissection was performed based on vimentin staining on a serial reference slide as previously described [21] using the Leica LMD7000 (GIGA-Imaging platform) and followed by RNA extraction (TriZOL, Invitrogen) and purification (RNeasy mini kit, Qiagen Valencia, CA).
Statistical analyses
Statistical analysis was performed with the Prism software (Graphpad Software, San Diego, CA). For immunohistochemistry on human samples, associations between the different markers were studied using Fisher exact tests. Otherwise, results were analyzed with the nonparametric Mann Whitney test with one-tailed p-value. A p-value <0.05 was considered significant. In histograms, mean ± SEM is represented.
Results
EMT phenotypes induce a panel of soluble factors in vitro and in vivo
To examine whether EMT programs are involved in the regulation of potential soluble modulators of angiogenesis and inflammation, two human models of inducible EMT were used: the MDA-MB-468 mammary adenocarcinoma cell line and the A549 lung carcinoma cell line, in which EMT was induced by EGF or TGF-β respectively. In MDA-MB-468, a detailed characterization of EGF-induced EMT has been published previously [21] . We here confirmed EMT induction by observation of morphological changes ( Figure 1A ) and by RTqPCR, showing a decrease in E-cadherin and an increase in vimentin mRNA levels ( Figure   1B ). In A549, TGF-β treatment induced morphological changes (Supplemental Figure S1A ), a decrease in epithelial markers (i.e. E-cadherin, Cingulin and ZO-3,) and an increase in mesenchymal markers and EMT-TFs (i.e. Vimentin, Slug, Snail, and ZEB1) (Supplemental To establish a functional contribution of EMT pathways in soluble factor regulation, we investigated the well described EMT-associated transcription factors Slug and Snail in the process. Indeed, their expression was increased upon EMT induction in MDA-MB-468 ( Figure 3A ). As we observed that Snail siRNA knockdown affected Slug expression and vice versa (data not shown), we knocked both genes down. Though some variations were observed between the different control siRNA sequences used, combined siRNA repression of Slug and Snail strongly and reproducibly inhibited mRNA levels of IL-8, IL-6 and PAI-1 in EGF-treated MDA-MB-468 ( Figure 3A) . Similar results were observed in A549 ( Figure   S2 ). Inversely, ectopic expression of a degradation-resistant form of Snail, Snail-6SA [41] increased mRNA levels of all five factors, reaching significance for IL-6 and PAI-1 in MDA-MB-468 ( Figure 3B ) and for IL-8 and IL-6 in A549 (Supplemental Figure S2B) . Altogether, To characterize this EMT-associated pro-angiogenic activity further, conditioned medium was tested for chemotactic activity on HUVEC cells, where medium from EGF-treated MDA-MB-468 cells increased migration compared to control conditions (C and C+E) ( Figure   4G ), but did not affect HUVEC proliferation (data not shown). Inhibition with specific blocking antibodies showed that IL-6 and PAI-1 are necessary for HUVEC migration ( Figure   4H) . Surprisingly, inhibition of ICAM-1 or IL-8, which are well-known angiogenic compounds [42] [43] [44] [45] , did not affect migration, though the efficiency of blocking antibodies was validated using recombinant IL-8 and ICAM-1 proteins (Supplemental Figure S4 ). Taken together, these results suggest that IL-6, IL-8, PAI-1, ICAM-1 and GM-CSF are functional secreted mediators of EMT-induced pro-angiogenic activity in our models.
To investigate the impact of EMT-induced cytokines on inflammatory cell recruitment, we took advantage of the 3 day-sponge model. Sponge dissociation followed by FACS analysis enabled us to characterize the infiltration of the sponge by macrophages and myeloid cells. Figure 6A and Table 1 ). Most interestingly, vimentin expression by at least 10% of cancer cells was associated with increased density of CD105-positive blood vessels, compared to tumors containing less than 10% vimentin-positive cancer cells ( Figure   6B and Table 2 ). Likewise and corroborating our findings suggesting an EMT-mediated recruitment of MDSCs, the presence of EMT markers in triple-negative breast cancers was associated with increased tumor infiltration by CD33-positive myeloid cells ( Figure 6B and are pertinently supported by a few data linking EMT-signaling and specific cytokine secretion. The association between EMT features and IL-8 has already been reported by us and others in breast [47] and colorectal carcinoma cell lines [48] . Clinically, EMT features were found enriched in IL-8-positive hepatocellular carcinoma tissues [49] . Regarding the regulation of other cytokines through EMT, data are scarce. PAI-1 expression is nevertheless induced during EMT in Ras-transformed keratinocytes (HaCaT II-4) [50] and mesenchymallike breast cancer cells secrete high amounts of GM-CSF [51] . Although some data implicate membrane bound ICAM-1 in accelerating TGF-β-induced EMT in renal cells in the presence of its ligand (LFA-1) on the surface of monocytes [52, 53] , no data have clearly linked sICAM-1 expression to EMT.
Conversely, certain chemokines also act as EMT inducers. Independent studies have shown that IL-8 [54] and IL-6 [55] act as key mediators of EMT induction and maintenance in several cancer cell lines [54] . Also, a functional role of PAI-1 in the modulation of EMT programs has been reported in Ras-induced EMT of HaCAT II cells [50] and in a model of EMT-induced lung fibrosis [56] . In the latter, PAI-1 knockdown inhibited TGF-β-triggered EMT in murine epithelial cells. Taken together, these data suggest that induction of IL-8, IL-6 and PAI-1 might create a positive regulatory loop to maintain EMT.
Our findings also indicate that EMT-associated cytokines are regulated by the EMTtranscription factor Snail, even though other transcription factors are most likely involved.
Supporting our results, ectopic expression of Snail in the canine renal MDCK cell line accentuates IL-6 and IL-8 increase upon IL-1β stimulation [57] and Snail expression in head and neck carcinoma cells enhances IL-6 and IL-8 expression [58] . Functional inhibition of
Snail by ectopic expression of a dominant negative form in breast cancer cells decreases PAI-1 expression [59] . Other EMT-transcription factors such as Brachury [54] or Twist [60] have also been shown to promote IL-8 expression. Our previous data have also shown increased IL-8 expression in breast cancer cell lines depending on EMT-induced ZO-1 delocalization [47] . Taken reported. Nilsson and colleagues [64] have shown that IL-6 stimulates angiogenesis in the sponge assay. Furthermore, IL-6 stimulates HUVEC cell proliferation, tubule formation and vessel sprouting in aortic ring assays [65] and fibroblast-derived IL-6 was recently shown to promote angiogenesis in colorectal tumors [66] . Regarding PAI-1, it has been shown to exert dual effects on angiogenesis, contextually either stimulating or inhibiting angiogenesis [67] [68] [69] . IL-8 is a well-known pro-angiogenic cytokine, which acts both directly on endothelial cells [43, 44] and indirectly by recruiting pro-angiogenic inflammatory cells [33, 70] . Taken circulating levels are not only predictive of survival in metastatic breast cancer patients [71] but also correlated to tumor burden and the number of CTCs [72] . It is also interesting to note that little data today suggest that MDSCs promote not only EMT and cancer cell dissemination [73] but also angiogenesis [74] . Most interestingly, immunotherapy combined with anti-angiogenic low-dose anti-VEGFR2 monoclonal antibody decreases tumor infiltration by MDSCs and increases survival in breast cancer-bearing mice [75] .
Our results suggest that conditioned medium from EMT-positive cells is able to attract 
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